1.Ultrasound-guided rectus sheath block for improvement of feelings of abdominal distension
Kaoru Nishijima ; Norio Hashimoto ; Miwako Kobayashi ; Takako Morimoto ; Noriko Sakaguchi ; Akiko Nakanishi ; Yuko Tanaka ; Fumiko Koyama ; Shinichiro Zushi ; Kunitaka Shibata
Palliative Care Research 2012;7(1):526-529
We report a case in which feelings of abdominal distension and discomfort of the abdominal wall caused by malignant ascites were relieved by ultrasound-guided rectus sheath block. Case report: A 59-year-old man developed gastric cancer with malignant ascites and experienced feelings of abdominal distension, but no nausea, dyspnea, poor mobility, or limb edema. Symptom control was inadequate with diuretic therapy and abdominal paracentesis. Feelings of distension improved temporarily with ultrasound-guided rectus sheath block. A percutaneous catheter was then used to administer an infusion of 0.25% ropivacaine triweekly until his death 20 days later. Conclusion: Feelings of abdominal distension is one of various symptoms of severe ascites and is difficult to manage. Ultrasound-guided rectus sheath block can be used to relieve this symptom on a case-by-case basis.
2.Successful elimination of intractable lower limb neuropathic pain by pelvic tumor invasion using ultrasound-guided sciatic nerve block
Norio Hashimoto ; Kaoru Nishijima ; Miwako Kobayashi ; Chieko Kuwahara ; Takako Morimoto ; Noriko Sakaguchi ; Akiko Nakanishi ; Yuko Tanaka ; Fumiko Koyama ; Shinichiro Zushi ; Kunitaka Shibata
Palliative Care Research 2010;6(1):313-315
We report a case whose left lower limb neuropathic pain accompanied by pelvic tumor invasion was remarkably eliminated by ultrasound-guided sciatic nerve block. Case report: The subject was a sixty year old male. Pharmacological therapy was given according to the WHO analgesic ladder, but his left lower limb pain failed to respond to drugs. His intractable lower limb neuropathic pain was alleviated by ultrasound-guided sciatic nerve block. Drug delivery can be achieved with a percutaneous catheter and a disposable infusion pump. Infusions were run at 5mlh-1 with 0.1% ropivacaine. Conclusion: Neuropahic pain is sometimes hard to be controlled only by opioids or adjuvant analgesics, but there is a possibility of providing pain relief by combination use with nerve blocks. Interventional techniques can be highly effective but also have the potentiality to produce significant adverse effects. Many patients have factors which would be considered a near absolute contra-indication to the use of nerve blocks such as immuno-compromise or impairment of coagulation. Skillful application of peripheral neural blockade with ultrasound imaging broadens the options for providing optimal pain management. Palliat Care Res 2011; 6(1): 313-315
3.Antiplatelet Therapy May Be Insufficient to Prevent Stroke Recurrence Before Percutaneous Patent Foramen Ovale Closure
Hiroyuki KAWANO ; Yuko HONDA ; Takashi JOHNO ; Hibiku MARUOKA ; Kaoru NAKANISHI ; Mikito SAITO ; Kensuke OGATA ; Atsushi YAMAMICHI ; Ayane KAWATAKE ; Teruyuki HIRANO
Journal of Stroke 2023;25(2):307-310
4.Persistent Severe Paraparesis after an Epidural Anesthesia Using Ropivacaine
Utako MIYAMOTO ; Etsuko MIZUTAMARI ; Makoto TOKUNAGA ; Kaoru MATSUNAGA ; Ryoji NAKANISHI
The Japanese Journal of Rehabilitation Medicine 2020;57(8):757-765
Paraparesis is a rare and serious complication following epidural anesthesia. Abnormal findings on magnetic resonance imaging (MRI) help with the diagnosis;however, diagnosis is challenging in the absence of MRI abnormalities.We present the case of a 26-year-old pregnant woman who received combined spinal-epidural anesthesia for cesarean delivery. The following day, she developed muscle weakness and sensory disturbances in the right lower extremity, which were attributable to the continuous epidural analgesia with ropivacaine that was used during the cesarean delivery. MRI revealed no spinal canal abnormalities;however, skeletal muscle MRI performed in the subacute phase revealed abnormally high signals on T2 and fat suppression T2-weighted imaging in the right paraspinal muscle below the L3 level. Nerve conduction studies revealed reduced amplitude of compound muscle action potentials and sensory nerve action potentials recorded in the lower extremities. After a 4-month period of rehabilitation, the patient could walk independently with a right ankle-foot orthosis and crutch;however, her right leg palsy and sensory disturbances persisted. Here, we report the clinical course of a patient who developed lumbosacral radiculopathy attributable to ropivacaine-induced neurotoxicity. Additionally, we present a review of the literature.
5.Persistent Severe Paraparesis after an Epidural Anesthesia Using Ropivacaine
Utako MIYAMOTO ; Etsuko MIZUTAMARI ; Makoto TOKUNAGA ; Kaoru MATSUNAGA ; Ryoji NAKANISHI
The Japanese Journal of Rehabilitation Medicine 2020;():19038-
Paraparesis is a rare and serious complication following epidural anesthesia. Abnormal findings on magnetic resonance imaging (MRI) help with the diagnosis;however, diagnosis is challenging in the absence of MRI abnormalities.We present the case of a 26-year-old pregnant woman who received combined spinal-epidural anesthesia for cesarean delivery. The following day, she developed muscle weakness and sensory disturbances in the right lower extremity, which were attributable to the continuous epidural analgesia with ropivacaine that was used during the cesarean delivery. MRI revealed no spinal canal abnormalities;however, skeletal muscle MRI performed in the subacute phase revealed abnormally high signals on T2 and fat suppression T2-weighted imaging in the right paraspinal muscle below the L3 level. Nerve conduction studies revealed reduced amplitude of compound muscle action potentials and sensory nerve action potentials recorded in the lower extremities. After a 4-month period of rehabilitation, the patient could walk independently with a right ankle-foot orthosis and crutch;however, her right leg palsy and sensory disturbances persisted. Here, we report the clinical course of a patient who developed lumbosacral radiculopathy attributable to ropivacaine-induced neurotoxicity. Additionally, we present a review of the literature.